Buscopan labeled with carbon-14 and deuterium

被引:5
|
作者
Latli, Bachir [1 ]
Stiasni, Michael [2 ]
Hrapchak, Matt [1 ]
Li, Zhibin [1 ]
Grinberg, Nelu [1 ]
Lee, Heewon [1 ]
Busacca, Carl A. [1 ]
Senanayake, Chris H. [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Chem Dev, 900 Ridgebury Rd,POB 368, Ridgefield, CT 06877 USA
[2] Boehringer Ingelheim GmbH & Co KG, Binger Str 173, D-55216 Ingelheim, Germany
关键词
Buscopan; carbon-14; deuterium; hyoscine butyl bromide; radiosynthesis; tropic acid; TROPIC ACID; TROPANE ALKALOIDS; HYOSCINE BUTYLBROMIDE; KINETIC RESOLUTION; DERIVATIVES; ATROPINE; STEREOCHEMISTRY; BIOSYNTHESIS;
D O I
10.1002/jlcr.3463
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Hyosine butyl bromide, the active ingredient in Buscopan, is an anticholinergic and antimuscarinic drug used to treat pain and discomfort caused by abdominal cramps. A straightforward synthesis of carbon-14- and deuterium-labeled Buscopan was developed using scopolamine, n-butyl-1-C-14 bromide, and n-butyl-H-2(9) bromide, respectively. In a second carbon-14 synthesis, the radioactive carbon was incorporated in the tropic acid moiety to follow its metabolism. Herein, we describe the detailed preparations of carbon-14- and deuterium-labeled Buscopan.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 50 条
  • [1] Enzymatic synthesis of phenylpyruvic acid labeled with deuterium, tritium, and carbon-14
    Skowera, Katarzyna
    Kanska, Marianna
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2008, 51 (7-8): : 321 - 324
  • [2] Synthesis of a Potent Cathepsin S Inhibitor Labeled with Deuterium and Carbon-14
    Latli, Bachir
    Hrapchak, Matt
    Lorenz, Jon C.
    Busacca, Carl A.
    Senanayake, Chris
    CURRENT RADIOPHARMACEUTICALS, 2012, 5 (04) : 314 - 317
  • [3] Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14
    Samonina-Kosicka, J.
    Kanska, M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (06): : 317 - 320
  • [4] Synthesis of L-tryptophan labeled with carbon-14, deuterium and tritium.
    Boroda, E
    Kanska, M
    Kochman, A
    Kanski, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B207 - B207
  • [5] A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium
    Latli, Bachir
    Eriksson, Magnus
    Hrapchak, Matt
    Busacca, Carl A.
    Senanayake, Chris H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (08): : 300 - 304
  • [6] SYNTHESIS OF CARBON-14 LABELED DEOXYRIBONUCLEOSIDES
    WILLIAMS, DL
    CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1962, 40 (09): : 1742 - &
  • [7] A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium
    Latli, Bachir
    Hrapchak, Matt
    Gao, Joe J.
    Busacca, Carl A.
    Senanayake, Chris H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 (09): : 390 - 394
  • [8] SYNTHESIS OF ETHYLENEDIAMINE LABELED WITH CARBON-14
    KIGOSHI, K
    OKAMOTO, S
    BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1956, 29 (03) : 438 - 439
  • [9] Synthesis of the olanzapine labeled by carbon-14
    Saadatjoo, Naghi
    Javaheri, Mohsen
    Saemian, Nader
    Amini, Mohsen
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (08): : 325 - 327
  • [10] CARBON-14 LABELED SCHISTOSOMA MANSONI
    LEWERT, RM
    PARA, BJ
    JOURNAL OF PARASITOLOGY, 1965, 51 (2S2) : 42 - &